Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T13:53:38.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T08:20:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version of the study protocol, now listed as v2.15.0, and it has removed detailed descriptions of the study's inclusion and exclusion criteria for participants with relapsed or refractory primary mediastinal large B-cell lymphoma and Richter syndrome.
    Difference
    24%
    Check dated 2025-04-16T01:46:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:22:37.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T15:38:50.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:09:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.